Free Trial
→ Why July 22nd Could Mean Big Changes for Social Security (From Altimetry) (Ad) Buy COR Stock  Free COR Stock Alerts

Cencora (COR) Financials

Cencora logo
$296.92 +3.72 (+1.27%)
Closing price 06/18/2025 03:59 PM Eastern
Extended Trading
$294.00 -2.91 (-0.98%)
As of 06/18/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Cencora

Annual Income Statements for Cencora

This table shows Cencora's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024
Net Income / (Loss) Attributable to Common Shareholders		 -138 1,428 364 1,658 855 -3,409 1,540 1,699 1,745 1,509
Consolidated Net Income / (Loss)		 -138 1,428 364 1,616 854 -3,400 1,545 1,667 1,733 1,519
Net Income / (Loss) Continuing Operations		 -138 1,428 364 1,616 854 -3,400 1,545 1,667 1,733 1,519
Total Pre-Tax Income 		269 1,391 918 1,177 967 -5,294 2,222 2,183 2,161 2,004
Total Operating Income		 422 1,526 1,060 1,444 1,112 -5,135 2,354 2,366 2,341 2,175
Total Gross Profit		 3,529 4,273 4,546 4,612 5,138 5,192 6,943 8,296 8,959 9,910
Total Revenue		 135,962 146,850 153,144 167,940 179,589 189,894 213,989 238,587 262,173 293,959
Operating Revenue		 135,962 146,850 153,144 167,940 179,589 189,894 213,989 238,587 262,173 293,959
Total Cost of Revenue		 132,432 142,577 148,598 163,327 174,451 184,702 207,046 230,291 253,214 284,049
Operating Cost of Revenue		 132,432 142,577 148,598 163,327 174,451 184,702 207,046 230,291 253,214 284,049
Total Operating Expenses		 3,107 2,747 3,486 3,169 4,026 10,327 4,589 5,930 6,619 7,735
Selling, General & Admin Expense		 1,908 2,091 2,129 2,460 2,664 2,767 3,594 4,849 5,310 5,661
Depreciation Expense		 192 212 237 284 295 280 327 387 410 429
Amortization Expense		 56 152 161 181 167 111 178 307 554 663
Impairment Charge		 - 0.00 0.00 60 570 362 18 81 0.00 418
Restructuring Charge		 38 103 959 184 330 85 199 183 370 337
Other Special Charges / (Income)		 0.00 48 - - - 6,722 273 123 -25 227
Total Other Income / (Expense), net		 -153 -135 -142 -266 -145 -158 -132 -183 -180 -171
Interest & Investment Income		 -140 -140 -145 -217 -158 -138 -174 -211 -229 -157
Other Income / (Expense), net		 -14 5.05 2.73 -25 13 1.58 42 27 49 -14
Income Tax Expense		 407 -37 553 -438 113 -1,894 677 517 428 485
Net Income / (Loss) Attributable to Noncontrolling Interest		 - 0.00 0.00 -43 -1.23 9.16 4.68 -32 -13 10
Basic Earnings per Share		 ($0.63) $6.73 $1.67 $7.61 $4.07 ($16.65) $7.48 $8.15 $8.62 $7.60
Weighted Average Basic Shares Outstanding		 217.79M 212.21M 218.38M 217.87M 210.17M 204.78M 205.92M 208.47M 202.51M 198.50M
Diluted Earnings per Share		 ($0.63) $6.32 $1.64 $7.53 $4.04 ($16.65) $7.39 $8.04 $8.53 $7.53
Weighted Average Diluted Shares Outstanding		 217.79M 225.96M 221.60M 220.34M 211.84M 204.78M 208.47M 211.21M 204.59M 200.28M
Weighted Average Basic & Diluted Shares Outstanding		 222.80M 212.20M 218.30M 217.90M 210.17M 204.78M 205.92M 205.67M 200.71M 193.28M
Cash Dividends to Common per Share		 $1.16 $1.36 $1.46 $1.52 $1.60 $1.66 $1.76 $1.84 $1.94 $2.04

Quarterly Income Statements for Cencora

This table shows Cencora's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 295 480 435 480 351 602 421 483 3.38 489 718
Consolidated Net Income / (Loss)		 299 476 428 479 349 603 421 488 7.47 494 717
Net Income / (Loss) Continuing Operations		 299 476 428 479 349 603 421 488 7.47 494 717
Total Pre-Tax Income 		382 593 512 609 446 783 467 628 125 620 929
Total Operating Income		 455 633 561 670 477 823 553 672 127 706 1,036
Total Gross Profit		 1,986 2,146 2,295 2,265 2,253 2,469 2,538 2,411 2,492 2,558 3,060
Total Revenue		 61,174 62,847 63,457 66,947 68,922 72,253 68,414 74,241 79,050 81,487 75,454
Operating Revenue		 61,174 62,847 63,457 66,947 68,922 72,253 68,414 74,241 79,050 81,487 75,454
Total Cost of Revenue		 59,189 60,701 61,162 64,682 66,669 69,784 65,876 71,831 76,558 78,929 72,394
Operating Cost of Revenue		 59,189 60,701 61,162 64,682 66,669 69,784 65,876 71,831 76,558 78,929 72,394
Total Operating Expenses		 1,531 1,513 1,735 1,595 1,777 1,646 1,985 1,738 2,366 1,852 2,024
Selling, General & Admin Expense		 1,263 1,291 1,321 1,304 1,394 1,399 1,389 1,383 1,490 1,472 1,600
Depreciation Expense		 97 100 101 105 106 104 106 108 110 113 122
Amortization Expense		 73 72 141 170 171 166 166 165 167 166 138
Restructuring Charge		 82 37 157 83 93 56 98 68 115 84 152
Other Special Charges / (Income)		 15 13 16 -67 14 -79 226 14 66 17 12
Total Other Income / (Expense), net		 -72 -40 -48 -61 -31 -39 -86 -44 -1.46 -86 -108
Interest & Investment Income		 -52 -46 -64 -58 -61 -41 -64 -31 -21 -28 -104
Other Income / (Expense), net		 -21 6.33 16 -3.44 30 1.09 -22 -13 20 -58 -3.55
Income Tax Expense		 84 117 84 130 97 180 46 141 118 127 211
Net Income / (Loss) Attributable to Noncontrolling Interest		 3.94 -3.58 -7.19 -0.37 -1.59 1.51 0.43 4.13 4.08 5.12 -0.45
Basic Earnings per Share		 $1.43 $2.35 $2.15 $2.37 $1.75 $3.01 $2.11 $2.44 $0.04 $2.52 $3.70
Weighted Average Basic Shares Outstanding		 208.47M 204.03M 202.32M 202.35M 202.51M 200.08M 199.41M 198.26M 198.50M 193.76M 193.80M
Diluted Earnings per Share		 $1.40 $2.33 $2.13 $2.35 $1.72 $2.98 $2.09 $2.42 $0.04 $2.50 $3.68
Weighted Average Diluted Shares Outstanding		 211.21M 206.33M 204.26M 204.38M 204.59M 201.84M 201.18M 200.05M 200.28M 195.19M 195.09M
Weighted Average Basic & Diluted Shares Outstanding		 205.67M 202.26M 202.47M 202.17M 200.71M 199.48M 199.45M 197.05M 193.28M 193.92M 193.82M
Cash Dividends to Common per Share		 - $0.49 $0.49 $0.49 - $0.51 $0.51 $0.51 - $0.55 $0.55

Annual Cash Flow Statements for Cencora

This table details how cash moves in and out of Cencora's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024
Net Change in Cash & Equivalents		 359 574 -307 57 882 1,224 -1,528 523 -841 545
Net Cash From Operating Activities		 3,922 3,178 1,504 1,411 2,344 2,207 2,667 2,703 3,911 3,485
Net Cash From Continuing Operating Activities		 3,922 3,178 1,504 1,411 2,344 2,207 2,667 2,703 3,911 3,485
Net Income / (Loss) Continuing Operations		 -138 1,428 364 1,616 854 -3,400 1,545 1,667 1,733 1,519
Consolidated Net Income / (Loss)		 -138 1,428 364 1,616 854 -3,400 1,545 1,667 1,733 1,519
Depreciation Expense		 193 233 262 318 321 291 327 391 419 448
Amortization Expense		 63 160 170 192 176 117 188 319 562 671
Non-Cash Adjustments To Reconcile Net Income		 1,557 461 -79 -513 595 475 -95 270 442 650
Changes in Operating Assets and Liabilities, net		 2,248 897 786 -202 398 4,724 702 57 756 196
Net Cash From Investing Activities		 -2,931 -3,169 -498 -1,111 -376 -380 -6,142 -368 -2,602 -618
Net Cash From Continuing Investing Activities		 -2,931 -3,169 -498 -1,111 -376 -380 -6,142 -368 -2,602 -618
Purchase of Property, Plant & Equipment		 -232 -465 -466 -336 -310 -370 -438 -496 -458 -487
Acquisitions		 -2,633 -2,750 -73 -785 -64 -56 -5,726 -152 -2,153 -100
Divestitures		 17 0.00 12 - - 0.00 0.00 273 0.00 0.00
Other Investing Activities, net		 2.88 -14 3.11 2.50 -2.95 9.52 22 7.60 9.00 -31
Net Cash From Financing Activities		 -632 565 -1,313 -243 -1,087 -604 1,953 -1,753 -2,222 -2,331
Net Cash From Continuing Financing Activities		 -632 565 -1,313 -243 -1,087 -604 1,953 -1,753 -2,222 -2,331
Repayment of Debt		 -626 -8,140 -10,093 -25,845 -1,291 -772 -5,909 -5,921 -79,009 -70,789
Repurchase of Common Equity		 -1,859 -2,266 -330 -639 -674 -420 -82 -484 -1,181 -1,491
Payment of Dividends		 -254 -288 -320 -333 -339 -344 -367 -392 -399 -416
Issuance of Debt		 2,107 8,847 9,336 26,444 1,147 716 8,136 4,988 78,376 70,391
Other Financing Activities, net		 -0.52 2,413 94 130 70 150 175 56 -10 -26
Effect of Exchange Rate Changes		 - - - - 0.00 0.00 -3.73 -58 73 9.40

Quarterly Cash Flow Statements for Cencora

This table details how cash moves in and out of Cencora's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents		 291 -1,681 -224 -140 1,205 283 -751 1,191 -179 97 -1,216
Net Cash From Operating Activities		 1,164 710 630 745 1,827 885 -878 2,478 1,000 -2,719 3,351
Net Cash From Continuing Operating Activities		 1,164 710 630 745 1,827 885 -878 2,478 1,000 -2,719 3,351
Net Income / (Loss) Continuing Operations		 299 476 428 479 349 603 421 488 7.47 494 717
Consolidated Net Income / (Loss)		 299 476 428 479 349 603 421 488 7.47 494 717
Depreciation Expense		 98 100 101 106 111 110 113 114 111 114 124
Amortization Expense		 76 75 143 171 172 168 167 167 169 168 140
Non-Cash Adjustments To Reconcile Net Income		 158 80 90 123 150 55 59 51 486 114 98
Changes in Operating Assets and Liabilities, net		 533 -21 -133 -134 1,045 -51 -1,638 1,658 227 -3,608 2,272
Net Cash From Investing Activities		 -175 -1,511 -89 -819 -183 -66 -166 -144 -242 -343 -4,078
Net Cash From Continuing Investing Activities		 -175 -1,511 -89 -819 -183 -66 -166 -144 -242 -343 -4,078
Purchase of Property, Plant & Equipment		 -174 -76 -103 -104 -175 -74 -113 -118 -182 -106 -129
Acquisitions		 -28 -1,438 10 -719 -6.40 -5.56 -10 -29 -61 -191 -3,949
Other Investing Activities, net		 12 2.69 4.09 3.76 -1.54 14 -43 3.09 1.17 -46 0.75
Net Cash From Financing Activities		 -673 -964 -769 -82 -407 -552 323 -1,145 -957 3,209 -492
Net Cash From Continuing Financing Activities		 -673 -964 -769 -82 -407 -552 323 -1,145 -957 3,209 -492
Repayment of Debt		 -858 -1,951 -34,591 -14,013 -28,454 -11,277 -36,832 -9,306 -13,374 -13,489 -30,027
Repurchase of Common Equity		 -235 -807 - -100 -274 -386 -51 -550 -505 -385 -50
Payment of Dividends		 -96 -100 -102 -99 -98 -106 -107 -103 -101 -111 -111
Issuance of Debt		 509 1,937 33,916 14,115 28,408 11,262 37,309 8,801 13,020 17,260 29,692
Other Financing Activities, net		 7.16 -43 7.11 15 11 -45 3.87 13 2.90 -66 4.08
Effect of Exchange Rate Changes		 -25 84 4.68 16 -32 16 -29 2.82 20 -50 1.72

Annual Balance Sheets for Cencora

This table presents Cencora's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024
Total Assets		 27,963 33,638 35,316 37,670 39,172 44,275 57,338 56,561 62,559 67,102
Total Current Assets		 20,334 22,852 24,303 25,894 28,132 33,056 38,803 39,590 42,799 47,718
Cash & Equivalents		 2,167 2,742 2,435 2,493 3,374 4,598 2,547 3,388 2,592 3,133
Accounts Receivable		 8,223 9,176 10,303 11,314 12,387 13,846 18,167 18,453 20,911 23,872
Inventories, net		 9,755 10,724 11,461 11,919 11,060 12,589 15,368 15,556 17,455 18,999
Prepaid Expenses		 189 210 103 169 157 189 854 488 449 539
Other Current Assets		 - - - 0.00 1,147 1,345 1,272 1,532 1,315 1,176
Plant, Property, & Equipment, net		 1,193 1,531 1,798 1,892 1,771 1,485 2,163 2,135 2,135 2,181
Total Noncurrent Assets		 6,436 9,255 9,215 9,883 9,269 9,734 16,372 14,836 17,625 17,202
Goodwill		 4,144 5,991 6,044 6,664 6,706 6,707 9,031 8,504 9,574 9,318
Intangible Assets		 1,993 2,968 2,833 2,948 2,295 1,886 5,257 4,333 4,432 4,001
Noncurrent Deferred & Refundable Income Taxes		 - - - - 0.00 362 291 238 201 246
Other Noncurrent Operating Assets		 298 296 338 271 269 780 1,794 1,762 3,418 3,637
Total Liabilities & Shareholders' Equity		 27,963 33,638 35,316 37,670 39,172 44,275 57,338 56,561 62,559 67,102
Total Liabilities		 27,347 31,508 33,252 34,620 36,179 45,114 56,753 56,489 61,892 66,315
Total Current Liabilities		 21,578 25,280 26,818 27,870 29,581 33,853 41,359 43,478 48,831 54,277
Short-Term Debt		 0.00 610 12 152 139 501 300 1,070 641 576
Accounts Payable		 20,886 23,926 25,404 26,837 28,385 31,705 38,010 40,193 45,836 50,942
Accrued Expenses		 692 744 1,402 881 1,057 1,647 2,856 2,215 2,354 2,759
Total Noncurrent Liabilities		 5,768 6,228 6,434 6,750 6,597 11,261 15,395 13,011 13,061 12,038
Long-Term Debt		 3,493 3,576 3,430 4,159 4,034 3,618 6,384 4,632 4,146 3,812
Asset Retirement Reserve & Litigation Obligation		 - - - - 0.00 6,199 5,962 5,462 5,062 4,297
Noncurrent Deferred Revenue		 - - 84 300 284 285 281 320 311 292
Noncurrent Deferred & Payable Income Tax Liabilities		 1,944 2,215 2,493 1,829 1,860 686 1,685 1,620 1,658 1,644
Other Noncurrent Operating Liabilities		 85 160 75 110 419 473 1,083 977 1,885 1,994
Commitments & Contingencies		 - - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 616 2,129 2,064 3,050 2,993 -840 584 71 666 787
Total Preferred & Common Equity		 616 2,129 2,064 2,933 2,879 -1,019 223 -212 522 646
Total Common Equity		 616 2,129 2,064 2,933 2,879 -1,019 223 -212 522 646
Common Stock		 3,739 4,336 4,520 4,718 4,853 5,085 5,468 5,662 5,848 6,034
Retained Earnings		 1,164 2,304 2,395 3,721 4,235 518 1,671 2,978 4,324 5,417
Treasury Stock		 -4,151 -4,396 -4,755 -5,427 -6,098 -6,513 -6,470 -7,020 -8,247 -9,816
Accumulated Other Comprehensive Income / (Loss)		 -136 -114 -96 -79 -112 -109 -445 -1,831 -1,403 -989
Noncontrolling Interest		 - - - 117 114 179 361 283 144 141

Quarterly Balance Sheets for Cencora

This table presents Cencora's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Total Assets		 56,561 57,907 58,766 61,177 62,559 64,690 63,868 66,772 67,102 69,054 71,194
Total Current Assets		 39,590 40,708 39,990 40,987 42,799 44,859 44,161 47,307 47,718 49,987 46,535
Cash & Equivalents		 3,388 1,692 1,539 1,389 2,592 2,872 2,069 3,306 3,133 3,224 1,978
Accounts Receivable		 18,453 18,627 19,491 20,797 20,911 21,577 22,643 24,051 23,872 24,546 23,715
Inventories, net		 15,556 16,780 16,955 16,852 17,455 18,652 17,631 18,302 18,999 20,508 18,966
Prepaid Expenses		 488 1,994 488 493 449 493 512 460 539 516 575
Other Current Assets		 1,532 1,529 1,481 1,418 1,315 1,243 1,195 1,144 1,176 1,193 1,302
Plant, Property, & Equipment, net		 2,135 2,140 2,150 2,148 2,135 2,117 2,089 2,081 2,181 2,100 2,303
Total Noncurrent Assets		 14,836 15,059 16,627 18,043 17,625 17,714 17,617 17,384 17,202 16,968 22,356
Goodwill		 8,504 8,597 9,634 9,658 9,574 9,661 9,619 9,614 9,318 9,177 14,091
Intangible Assets		 4,333 4,430 4,885 4,767 4,432 4,376 4,176 4,011 4,001 3,682 3,863
Noncurrent Deferred & Refundable Income Taxes		 238 230 229 221 201 218 257 230 246 219 234
Other Noncurrent Operating Assets		 1,762 1,802 1,880 3,396 3,418 3,459 3,566 3,530 3,637 3,889 4,168
Total Liabilities & Shareholders' Equity		 56,561 57,907 58,766 61,177 62,559 64,690 63,868 66,772 67,102 69,054 71,194
Total Liabilities		 56,489 57,833 58,255 60,255 61,892 63,629 62,641 65,712 66,315 68,692 70,014
Total Current Liabilities		 43,478 44,761 45,071 46,783 48,831 50,773 49,762 52,974 54,277 54,509 53,328
Short-Term Debt		 1,070 988 266 861 641 593 1,069 565 576 2,213 770
Accounts Payable		 40,193 41,758 42,735 43,752 45,836 47,743 46,321 49,883 50,942 49,911 50,111
Accrued Expenses		 2,215 2,014 2,070 2,170 2,354 2,437 2,372 2,526 2,759 2,385 2,447
Total Noncurrent Liabilities		 13,011 13,073 13,184 13,472 13,061 12,856 12,879 12,738 12,038 14,183 16,686
Long-Term Debt		 4,632 4,656 4,667 4,160 4,146 4,186 4,180 4,166 3,812 5,935 7,086
Asset Retirement Reserve & Litigation Obligation		 5,462 5,463 5,448 5,455 5,062 4,732 4,720 4,698 4,297 4,297 4,285
Noncurrent Deferred Revenue		 320 329 272 284 311 335 316 332 292 303 278
Noncurrent Deferred & Payable Income Tax Liabilities		 1,620 1,633 1,742 1,716 1,658 1,691 1,702 1,608 1,644 1,586 1,616
Other Noncurrent Operating Liabilities		 977 992 1,055 1,857 1,885 1,912 1,962 1,934 1,994 2,062 3,422
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 71 74 511 922 666 1,061 1,227 1,061 787 362 1,180
Total Preferred & Common Equity		 -212 -178 282 686 522 912 1,083 925 646 227 1,013
Total Common Equity		 -212 -178 282 686 522 912 1,083 925 646 227 1,013
Common Stock		 5,662 5,740 5,773 5,811 5,848 5,920 5,957 5,992 6,034 6,109 6,145
Retained Earnings		 2,978 3,358 3,691 4,072 4,324 4,820 5,134 5,515 5,417 5,795 6,402
Treasury Stock		 -7,020 -7,864 -7,867 -7,970 -8,247 -8,692 -8,747 -9,302 -9,816 -10,278 -10,332
Accumulated Other Comprehensive Income / (Loss)		 -1,831 -1,412 -1,316 -1,227 -1,403 -1,136 -1,260 -1,279 -989 -1,400 -1,202
Noncontrolling Interest		 283 252 229 236 144 150 144 135 141 135 167

Annual Metrics And Ratios for Cencora

This table displays calculated financial ratios and metrics derived from Cencora's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 13.71% 8.01% 4.29% 9.66% 6.94% 5.74% 12.69% 11.50% 9.89% 12.12%
EBITDA Growth		 -32.39% 189.34% -22.24% 28.95% -15.87% -391.28% 161.59% 6.63% 8.60% -2.69%
EBIT Growth		 -48.04% 274.63% -30.56% 33.41% -20.68% -556.39% 146.67% -0.09% -0.17% -9.57%
NOPAT Growth		 -165.93% 822.20% -73.12% 370.56% -50.44% -466.05% 145.53% 10.38% 3.89% -12.13%
Net Income Growth		 -150.38% 1,133.50% -74.47% 343.34% -47.14% -498.01% 145.44% 7.89% 3.96% -12.31%
EPS Growth		 -154.31% 1,103.17% -74.05% 359.15% -46.35% -512.13% 144.38% 8.80% 6.09% -11.72%
Operating Cash Flow Growth		 167.79% -18.96% -52.68% -6.17% 66.08% -5.84% 20.82% 1.37% 44.70% -10.91%
Free Cash Flow Firm Growth		 -138.94% 63.33% 986.26% -78.26% 1,206.87% -37.14% -378.65% 193.83% -64.63% 76.20%
Invested Capital Growth		 2.06% 75.96% -11.10% 52.49% -27.36% -134.75% 444.52% -47.45% 19.94% -28.64%
Revenue Q/Q Growth		 2.94% 1.44% 1.03% 2.55% 1.32% 1.94% 4.73% 0.96% 3.05% 3.57%
EBITDA Q/Q Growth		 113.64% -13.03% -19.15% 18.90% 0.75% -399.41% 174.98% -5.33% 5.74% -10.02%
EBIT Q/Q Growth		 424.74% -16.99% -25.45% 25.83% 2.38% -544.09% 155.44% -6.80% 3.17% -14.32%
NOPAT Q/Q Growth		 -442.79% -13.66% -55.57% 42.41% -7.76% -295.75% 154.11% -4.70% 0.90% -18.40%
Net Income Q/Q Growth		 68.14% -13.10% -57.36% 49.99% -6.74% -315.54% 141.34% -7.64% 2.99% -18.35%
EPS Q/Q Growth		 69.42% -14.59% -57.29% 54.30% -10.02% -319.37% 140.40% -7.80% 3.90% -18.24%
Operating Cash Flow Q/Q Growth		 9.18% 6.45% 1.75% -33.63% 0.32% 39.63% -9.79% 6.07% 20.39% -19.17%
Free Cash Flow Firm Q/Q Growth		 -2,163.04% -158.58% 148.78% -75.95% -0.60% 5.16% -28.14% 19.73% 64.45% -39.63%
Invested Capital Q/Q Growth		 -21.02% -12.92% -31.92% -7.65% -11.66% -128.11% -8.42% -32.70% -37.15% -17.83%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 2.60% 2.91% 2.97% 2.75% 2.86% 2.73% 3.24% 3.48% 3.42% 3.37%
EBITDA Margin		 0.49% 1.31% 0.98% 1.15% 0.90% -2.49% 1.36% 1.30% 1.29% 1.12%
Operating Margin		 0.31% 1.04% 0.69% 0.86% 0.62% -2.70% 1.10% 0.99% 0.89% 0.74%
EBIT Margin		 0.30% 1.04% 0.69% 0.84% 0.63% -2.70% 1.12% 1.00% 0.91% 0.74%
Profit (Net Income) Margin		 -0.10% 0.97% 0.24% 0.96% 0.48% -1.79% 0.72% 0.70% 0.66% 0.52%
Tax Burden Percent		 -51.37% 102.66% 39.71% 137.24% 88.32% 64.22% 69.52% 76.34% 80.18% 75.81%
Interest Burden Percent		 65.82% 90.86% 86.34% 83.02% 85.97% 103.12% 92.73% 91.20% 90.42% 92.74%
Effective Tax Rate		 151.37% -2.66% 60.29% -37.24% 11.68% 0.00% 30.48% 23.66% 19.82% 24.19%
Return on Invested Capital (ROIC)		 -10.01% 51.88% 11.58% 45.85% 21.79% -290.60% 101.57% 52.16% 71.53% 67.26%
ROIC Less NNEP Spread (ROIC-NNEP)		 -1.06% 43.47% 7.90% 25.14% 13.18% -168.78% 96.28% 47.70% 65.13% 59.73%
Return on Net Nonoperating Assets (RNNOA)		 -0.73% 52.13% 5.80% 17.34% 6.47% -25.12% -1,311.96% 456.17% 398.28% 141.86%
Return on Equity (ROE)		 -10.74% 104.01% 17.38% 63.19% 28.27% -315.71% -1,210.39% 508.34% 469.81% 209.12%
Cash Return on Invested Capital (CROIC)		 -12.05% -3.17% 23.33% 4.27% 53.49% 0.00% -92.98% 114.37% 53.40% 100.68%
Operating Return on Assets (OROA)		 1.65% 4.97% 3.08% 3.89% 2.93% -12.30% 4.72% 4.20% 4.01% 3.33%
Return on Assets (ROA)		 -0.56% 4.64% 1.06% 4.43% 2.22% -8.15% 3.04% 2.93% 2.91% 2.34%
Return on Common Equity (ROCE)		 -10.74% 104.01% 17.38% 61.74% 27.19% -272.68% -3,772.94% 9.14% 197.75% 168.09%
Return on Equity Simple (ROE_SIMPLE)		 -22.42% 67.06% 17.66% 55.10% 29.67% 333.64% 691.55% -787.74% 331.91% 235.20%
Net Operating Profit after Tax (NOPAT)		 -217 1,566 421 1,981 982 -3,595 1,637 1,806 1,877 1,649
NOPAT Margin		 -0.16% 1.07% 0.27% 1.18% 0.55% -1.89% 0.76% 0.76% 0.72% 0.56%
Net Nonoperating Expense Percent (NNEP)		 -8.95% 8.41% 3.67% 20.71% 8.62% -121.81% 5.29% 4.46% 6.40% 7.53%
Cost of Revenue to Revenue		 97.40% 97.09% 97.03% 97.25% 97.14% 97.27% 96.76% 96.52% 96.58% 96.63%
SG&A Expenses to Revenue		 1.40% 1.42% 1.39% 1.47% 1.48% 1.46% 1.68% 2.03% 2.03% 1.93%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 2.29% 1.87% 2.28% 1.89% 2.24% 5.44% 2.14% 2.49% 2.52% 2.63%
Earnings before Interest and Taxes (EBIT)		 409 1,531 1,063 1,418 1,125 -5,134 2,396 2,394 2,390 2,161
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 665 1,923 1,495 1,928 1,622 -4,726 2,911 3,104 3,371 3,280
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 23.09 5.91 6.72 5.49 5.12 0.00 107.09 0.00 68.91 68.51
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.10 0.09 0.09 0.10 0.08 0.10 0.11 0.11 0.14 0.15
Price to Earnings (P/E)		 0.00 8.81 38.05 9.72 17.24 0.00 15.53 16.08 20.61 29.32
Dividend Yield		 4.31% 5.94% 7.68% 7.44% 8.82% 7.39% 5.87% 1.40% 1.36% 0.91%
Earnings Yield		 0.00% 11.35% 2.63% 10.29% 5.80% 0.00% 6.44% 6.22% 4.85% 3.41%
Enterprise Value to Invested Capital (EV/IC)		 7.22 3.71 4.45 3.52 4.13 0.00 6.26 12.54 13.39 22.35
Enterprise Value to Revenue (EV/Rev)		 0.12 0.10 0.10 0.11 0.09 0.09 0.13 0.13 0.15 0.16
Enterprise Value to EBITDA (EV/EBITDA)		 23.78 7.44 10.18 9.54 9.65 0.00 9.76 9.64 11.37 13.92
Enterprise Value to EBIT (EV/EBIT)		 38.67 9.34 14.32 12.97 13.92 0.00 11.86 12.50 16.03 21.12
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 9.13 36.17 9.29 15.94 0.00 17.36 16.56 20.41 27.68
Enterprise Value to Operating Cash Flow (EV/OCF)		 4.03 4.50 10.12 13.04 6.68 8.05 10.66 11.07 9.80 13.10
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 17.95 99.77 6.50 11.72 0.00 7.55 27.34 18.49
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 6.07 2.10 1.84 1.53 1.39 -4.91 11.44 80.01 7.19 5.58
Long-Term Debt to Equity		 6.07 1.81 1.83 1.48 1.35 -4.31 10.92 64.99 6.22 4.85
Financial Leverage		 0.68 1.20 0.73 0.69 0.49 0.15 -13.63 9.56 6.11 2.37
Leverage Ratio		 19.23 22.43 16.44 14.27 12.72 38.75 -398.13 173.71 161.50 89.23
Compound Leverage Factor		 12.66 20.38 14.20 11.85 10.93 39.96 -369.20 158.42 146.03 82.75
Debt to Total Capital		 85.85% 67.70% 64.76% 60.45% 58.23% 125.60% 91.96% 98.77% 87.78% 84.80%
Short-Term Debt to Total Capital		 0.00% 9.26% 0.21% 1.97% 1.94% 15.28% 4.13% 18.54% 11.76% 11.14%
Long-Term Debt to Total Capital		 85.85% 58.44% 64.55% 58.49% 56.29% 110.32% 87.83% 80.23% 76.02% 73.66%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 1.52% 1.59% 5.47% 4.97% 4.90% 2.65% 2.72%
Common Equity to Total Capital		 14.15% 32.30% 35.24% 38.03% 40.17% -31.07% 3.07% -3.66% 9.57% 12.48%
Debt to EBITDA		 5.63 2.32 2.54 2.42 2.57 -0.87 2.30 1.84 1.42 1.34
Net Debt to EBITDA		 2.37 0.89 0.91 1.13 0.49 0.10 1.42 0.75 0.65 0.38
Long-Term Debt to EBITDA		 5.63 2.00 2.53 2.34 2.49 -0.77 2.19 1.49 1.23 1.16
Debt to NOPAT		 -17.24 2.85 9.01 2.35 4.25 -1.15 4.08 3.16 2.55 2.66
Net Debt to NOPAT		 -7.25 1.10 3.23 1.10 0.81 0.13 2.53 1.28 1.17 0.76
Long-Term Debt to NOPAT		 -17.24 2.46 8.98 2.28 4.11 -1.01 3.90 2.56 2.21 2.31
Altman Z-Score		 5.23 4.76 4.70 4.94 5.03 4.14 4.11 4.64 4.65 4.88
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 2.29% 3.83% 13.63% -211.71% 98.20% 57.91% 19.62%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 0.94 0.90 0.91 0.93 0.95 0.98 0.94 0.91 0.88 0.88
Quick Ratio		 0.48 0.47 0.48 0.50 0.53 0.54 0.50 0.50 0.48 0.50
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -261 -96 848 184 2,410 1,515 -4,222 3,961 1,401 2,469
Operating Cash Flow to CapEx		 1,693.65% 684.11% 322.50% 429.89% 758.76% 662.15% 608.51% 544.63% 853.33% 715.29%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 7.76 0.00 68.32 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 59.39 0.00 99.53 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 45.57 0.00 84.50 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 5.49 4.77 4.44 4.60 4.67 4.55 4.21 4.19 4.40 4.53
Accounts Receivable Turnover		 18.71 16.88 15.72 15.54 15.15 14.48 13.37 13.03 13.32 13.13
Inventory Turnover		 14.43 13.92 13.40 13.97 15.18 15.62 14.81 14.89 15.34 15.58
Fixed Asset Turnover		 129.98 107.85 92.02 91.02 98.06 116.67 117.33 111.02 122.79 136.20
Accounts Payable Turnover		 7.26 6.36 6.02 6.25 6.32 6.15 5.94 5.89 5.89 5.87
Days Sales Outstanding (DSO)		 19.51 21.62 23.21 23.49 24.09 25.21 27.30 28.01 27.40 27.80
Days Inventory Outstanding (DIO)		 25.29 26.21 27.25 26.12 24.04 23.37 24.64 24.51 23.79 23.42
Days Payable Outstanding (DPO)		 50.27 57.36 60.58 58.37 57.77 59.37 61.45 61.97 62.00 62.18
Cash Conversion Cycle (CCC)		 -5.47 -9.52 -10.12 -8.76 -9.65 -10.79 -9.50 -9.46 -10.81 -10.96
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 2,188 3,850 3,423 5,220 3,792 -1,318 4,540 2,386 2,862 2,042
Invested Capital Turnover		 62.77 48.64 42.11 38.86 39.86 153.51 132.81 68.89 99.92 119.89
Increase / (Decrease) in Invested Capital		 44 1,662 -427 1,797 -1,428 -5,110 5,858 -2,154 476 -820
Enterprise Value (EV)		 15,803 14,299 15,227 18,398 15,656 17,760 28,416 29,920 38,311 45,647
Market Capitalization		 14,231 12,579 13,869 16,111 14,743 18,059 23,918 27,323 35,972 44,251
Book Value per Share		 $2.85 $9.92 $9.42 $13.56 $13.82 ($4.99) $1.07 ($1.02) $2.58 $3.28
Tangible Book Value per Share		 ($25.54) ($31.81) ($31.09) ($30.87) ($29.38) ($47.08) ($67.69) ($62.96) ($66.69) ($64.32)
Total Capital		 4,356 6,592 5,858 7,712 7,166 3,280 7,268 5,774 5,454 5,175
Total Debt		 3,739 4,463 3,794 4,662 4,173 4,120 6,684 5,703 4,787 4,388
Total Long-Term Debt		 3,739 3,852 3,782 4,511 4,034 3,618 6,384 4,632 4,146 3,812
Net Debt		 1,572 1,721 1,359 2,170 799 -478 4,137 2,315 2,195 1,255
Capital Expenditures (CapEx)		 232 465 466 328 309 333 438 496 458 487
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -3,411 -4,560 -4,938 -4,316 -4,684 -4,894 -4,803 -6,206 -7,983 -9,116
Debt-free Net Working Capital (DFNWC)		 -1,244 -1,818 -2,503 -1,824 -1,310 -296 -2,256 -2,818 -5,391 -5,983
Net Working Capital (NWC)		 -1,244 -2,429 -2,515 -1,975 -1,449 -797 -2,556 -3,888 -6,032 -6,559
Net Nonoperating Expense (NNE)		 -79 138 57 365 128 -195 92 140 144 130
Net Nonoperating Obligations (NNO)		 1,572 1,721 1,359 2,170 799 -478 3,956 2,315 2,195 1,255
Total Depreciation and Amortization (D&A)		 256 392 432 510 498 408 515 710 981 1,119
Debt-free, Cash-free Net Working Capital to Revenue		 -2.51% -3.11% -3.22% -2.57% -2.61% -2.58% -2.24% -2.60% -3.05% -3.10%
Debt-free Net Working Capital to Revenue		 -0.91% -1.24% -1.63% -1.09% -0.73% -0.16% -1.05% -1.18% -2.06% -2.04%
Net Working Capital to Revenue		 -0.91% -1.65% -1.64% -1.18% -0.81% -0.42% -1.19% -1.63% -2.30% -2.23%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.62) $6.73 $1.67 $0.00 $4.07 ($16.65) $7.48 $8.15 $8.62 $7.60
Adjusted Weighted Average Basic Shares Outstanding		 217.79M 212.21M 218.38M 0.00 210.17M 204.78M 205.92M 208.47M 202.51M 198.50M
Adjusted Diluted Earnings per Share		 ($0.62) $6.32 $1.64 $0.00 $4.04 ($16.65) $7.39 $8.04 $8.53 $7.53
Adjusted Weighted Average Diluted Shares Outstanding		 217.79M 225.96M 221.60M 0.00 211.84M 204.78M 208.47M 211.21M 204.59M 200.28M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 205.63M 220.10M 218.08M 0.00 205.92M 204.25M 205.92M 205.67M 200.71M 193.28M
Normalized Net Operating Profit after Tax (NOPAT)		 322 1,173 1,414 1,181 1,777 1,424 1,977 2,102 2,153 2,393
Normalized NOPAT Margin		 0.24% 0.80% 0.92% 0.70% 0.99% 0.75% 0.92% 0.88% 0.82% 0.81%
Pre Tax Income Margin		 0.20% 0.95% 0.60% 0.70% 0.54% -2.79% 1.04% 0.92% 0.82% 0.68%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 59.67 0.00 -231.51 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 83.37 0.00 -162.11 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 45.86 0.00 -246.54 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 69.55 0.00 -177.14 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 -183.78% 20.20% 87.87% 20.61% 39.69% -10.11% 23.74% 23.50% 23.02% 27.39%
Augmented Payout Ratio		 -1,529.35% 178.92% 178.39% 60.17% 118.60% -22.47% 29.06% 52.53% 91.16% 125.56%

Quarterly Metrics And Ratios for Cencora

This table displays calculated financial ratios and metrics derived from Cencora's official financial filings.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 3.84% 5.40% 9.94% 11.46% 12.67% 14.97% 7.81% 10.90% 14.69% 12.78% 10.29%
EBITDA Growth		 -22.32% -1.82% -14.54% 33.91% 30.07% 35.28% -1.23% -0.33% -46.16% -15.65% 59.89%
EBIT Growth		 -28.70% -1.56% -26.23% 25.98% 16.94% 28.85% -7.82% -1.05% -71.20% -21.31% 94.40%
NOPAT Growth		 -19.80% 4.58% -21.21% 41.95% 5.01% 24.68% 6.46% -1.06% -97.97% -11.27% 60.44%
Net Income Growth		 -31.57% 5.95% -22.88% 31.94% 16.84% 26.64% -1.64% 1.75% -97.86% -18.12% 70.32%
EPS Growth		 -32.69% 9.39% -17.76% 22.40% 22.86% 27.90% -1.88% 2.98% -97.67% -16.11% 76.08%
Operating Cash Flow Growth		 15.32% -17.76% 136.14% 82.30% 56.88% 24.66% -239.54% 232.59% -45.24% -407.15% 481.50%
Free Cash Flow Firm Growth		 146.34% 107.93% 118.57% -126.94% -104.10% 314.68% -100.54% 638.87% 903.46% -203.85% -44,525.33%
Invested Capital Growth		 -47.45% 2.55% -7.25% 28.43% 19.94% -26.28% 12.88% -45.42% -28.64% 78.13% 60.13%
Revenue Q/Q Growth		 1.85% 2.73% 0.97% 5.50% 2.95% 4.83% -5.31% 8.52% 6.48% 3.08% -7.40%
EBITDA Q/Q Growth		 -13.71% 34.00% 0.75% 14.94% -16.18% 39.36% -26.44% 15.98% -54.72% 118.33% 39.44%
EBIT Q/Q Growth		 -18.01% 47.39% -9.89% 15.70% -23.90% 62.40% -35.53% 24.18% -77.85% 343.65% 59.27%
NOPAT Q/Q Growth		 -4.44% 43.08% -7.74% 12.54% -29.32% 69.89% -21.23% 4.59% -98.55% 7,340.55% 42.44%
Net Income Q/Q Growth		 -17.77% 59.43% -10.07% 11.91% -27.18% 72.79% -30.15% 15.76% -98.47% 6,512.90% 45.31%
EPS Q/Q Growth		 -27.08% 66.43% -8.58% 10.33% -26.81% 73.26% -29.87% 15.79% -98.35% 6,150.00% 47.20%
Operating Cash Flow Q/Q Growth		 184.97% -39.02% -11.35% 18.34% 145.23% -51.55% -199.24% 382.04% -59.62% -371.78% 223.26%
Free Cash Flow Firm Q/Q Growth		 40.65% -83.75% 89.76% -162.10% 78.58% 1,743.13% -100.25% 62,579.69% -68.07% -312.38% -5.31%
Invested Capital Q/Q Growth		 -32.70% 68.73% -3.01% 16.62% -37.15% 3.70% 48.52% -43.61% -17.83% 158.85% 33.52%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 3.25% 3.41% 3.62% 3.38% 3.27% 3.42% 3.71% 3.25% 3.15% 3.14% 4.06%
EBITDA Margin		 0.99% 1.30% 1.29% 1.41% 1.15% 1.53% 1.19% 1.27% 0.54% 1.14% 1.72%
Operating Margin		 0.74% 1.01% 0.88% 1.00% 0.69% 1.14% 0.81% 0.91% 0.16% 0.87% 1.37%
EBIT Margin		 0.71% 1.02% 0.91% 1.00% 0.74% 1.14% 0.78% 0.89% 0.18% 0.80% 1.37%
Profit (Net Income) Margin		 0.49% 0.76% 0.67% 0.72% 0.51% 0.83% 0.62% 0.66% 0.01% 0.61% 0.95%
Tax Burden Percent		 78.12% 80.24% 83.61% 78.71% 78.17% 76.97% 90.18% 77.60% 5.96% 79.57% 77.25%
Interest Burden Percent		 88.12% 92.80% 88.87% 91.32% 87.99% 95.08% 87.93% 95.25% 85.65% 95.69% 89.93%
Effective Tax Rate		 21.88% 19.76% 16.39% 21.29% 21.83% 23.03% 9.82% 22.40% 94.04% 20.43% 22.75%
Return on Invested Capital (ROIC)		 39.99% 49.17% 45.06% 49.50% 54.05% 68.09% 48.53% 56.69% 1.15% 50.67% 57.41%
ROIC Less NNEP Spread (ROIC-NNEP)		 38.19% 48.29% 43.85% 48.05% 52.99% 67.05% 46.16% 55.33% 1.14% 48.67% 55.58%
Return on Net Nonoperating Assets (RNNOA)		 365.21% 520.81% 207.24% 222.22% 324.05% 346.14% 174.59% 141.12% 2.71% 233.60% 209.18%
Return on Equity (ROE)		 405.19% 569.98% 252.30% 271.73% 378.11% 414.23% 223.11% 197.81% 3.85% 284.27% 266.59%
Cash Return on Invested Capital (CROIC)		 114.37% 43.49% 49.50% 21.04% 53.40% 87.50% 36.67% 116.19% 100.68% -17.98% -13.38%
Operating Return on Assets (OROA)		 2.97% 4.26% 3.87% 4.28% 3.24% 5.05% 3.50% 3.94% 0.84% 3.61% 6.29%
Return on Assets (ROA)		 2.05% 3.17% 2.88% 3.08% 2.23% 3.70% 2.78% 2.91% 0.04% 2.75% 4.37%
Return on Common Equity (ROCE)		 7.29% 53.57% 148.12% 171.79% 159.15% 267.77% 175.19% 160.76% 3.10% 227.36% 232.16%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -950.59% 556.03% 245.22% 0.00% 203.95% 171.02% 201.12% 0.00% 622.29% 168.46%
Net Operating Profit after Tax (NOPAT)		 355 508 469 527 373 633 499 522 7.55 562 800
NOPAT Margin		 0.58% 0.81% 0.74% 0.79% 0.54% 0.88% 0.73% 0.70% 0.01% 0.69% 1.06%
Net Nonoperating Expense Percent (NNEP)		 1.80% 0.88% 1.21% 1.45% 1.06% 1.04% 2.36% 1.36% 0.01% 2.00% 1.83%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - 10.85% - - - 6.60% 8.86%
Cost of Revenue to Revenue		 96.75% 96.59% 96.38% 96.62% 96.73% 96.58% 96.29% 96.75% 96.85% 96.86% 95.94%
SG&A Expenses to Revenue		 2.07% 2.05% 2.08% 1.95% 2.02% 1.94% 2.03% 1.86% 1.89% 1.81% 2.12%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 2.50% 2.41% 2.73% 2.38% 2.58% 2.28% 2.90% 2.34% 2.99% 2.27% 2.68%
Earnings before Interest and Taxes (EBIT)		 434 639 576 667 507 824 531 660 146 648 1,033
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 608 815 821 944 791 1,102 811 941 426 930 1,297
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 113.29 56.13 68.91 45.14 44.55 48.46 68.51 191.66 53.24
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.11 0.14 0.13 0.15 0.14 0.15 0.17 0.16 0.15 0.14 0.17
Price to Earnings (P/E)		 16.08 19.36 19.74 22.79 20.61 22.04 26.05 24.16 29.32 31.10 31.85
Dividend Yield		 1.40% 1.44% 1.51% 1.26% 1.36% 0.97% 0.82% 0.90% 0.91% 0.93% 0.76%
Earnings Yield		 6.22% 5.17% 5.07% 4.39% 4.85% 4.54% 3.84% 4.14% 3.41% 3.22% 3.14%
Enterprise Value to Invested Capital (EV/IC)		 12.54 9.36 9.10 9.31 13.39 14.56 11.70 18.67 22.35 9.17 8.50
Enterprise Value to Revenue (EV/Rev)		 0.13 0.16 0.14 0.17 0.15 0.16 0.19 0.16 0.16 0.16 0.19
Enterprise Value to EBITDA (EV/EBITDA)		 9.64 12.20 12.05 13.29 11.37 11.81 14.14 12.73 13.92 15.60 16.69
Enterprise Value to EBIT (EV/EBIT)		 12.50 15.81 16.31 18.29 16.03 16.79 20.39 18.40 21.12 24.42 24.12
Enterprise Value to NOPAT (EV/NOPAT)		 16.56 20.60 20.87 22.78 20.41 21.59 25.45 22.96 27.68 30.75 31.84
Enterprise Value to Operating Cash Flow (EV/OCF)		 11.07 14.78 12.20 13.04 9.80 10.57 20.01 10.76 13.10 0.00 14.59
Enterprise Value to Free Cash Flow (EV/FCFF)		 7.55 21.80 17.70 49.73 27.34 14.12 33.85 11.35 18.49 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 80.01 76.73 9.65 5.45 7.19 4.50 4.28 4.46 5.58 22.52 6.66
Long-Term Debt to Equity		 64.99 63.30 9.13 4.51 6.22 3.94 3.41 3.93 4.85 16.40 6.01
Financial Leverage		 9.56 10.79 4.73 4.62 6.11 5.16 3.78 2.55 2.37 4.80 3.76
Leverage Ratio		 173.71 171.17 81.90 82.19 161.50 108.03 70.55 64.54 89.23 93.98 56.12
Compound Leverage Factor		 153.08 158.85 72.79 75.06 142.11 102.71 62.04 61.47 76.43 89.93 50.47
Debt to Total Capital		 98.77% 98.71% 90.61% 84.48% 87.78% 81.83% 81.05% 81.69% 84.80% 95.75% 86.94%
Short-Term Debt to Total Capital		 18.54% 17.28% 4.89% 14.49% 11.76% 10.15% 16.51% 9.76% 11.14% 26.01% 8.53%
Long-Term Debt to Total Capital		 80.23% 81.43% 85.72% 70.00% 76.02% 71.68% 64.55% 71.93% 73.66% 69.74% 78.42%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 4.90% 4.40% 4.21% 3.97% 2.65% 2.56% 2.22% 2.34% 2.72% 1.59% 1.85%
Common Equity to Total Capital		 -3.66% -3.12% 5.17% 11.54% 9.57% 15.61% 16.72% 15.98% 12.48% 2.66% 11.21%
Debt to EBITDA		 1.84 1.83 1.67 1.58 1.42 1.31 1.44 1.30 1.34 2.62 2.19
Net Debt to EBITDA		 0.75 1.28 1.15 1.14 0.65 0.52 0.87 0.39 0.38 1.58 1.64
Long-Term Debt to EBITDA		 1.49 1.51 1.58 1.31 1.23 1.14 1.15 1.14 1.16 1.91 1.97
Debt to NOPAT		 3.16 3.09 2.90 2.70 2.55 2.39 2.59 2.34 2.66 5.17 4.17
Net Debt to NOPAT		 1.28 2.16 1.99 1.95 1.17 0.95 1.57 0.71 0.76 3.12 3.12
Long-Term Debt to NOPAT		 2.56 2.55 2.74 2.24 2.21 2.09 2.06 2.06 2.31 3.76 3.76
Altman Z-Score		 4.53 4.56 4.56 4.56 4.55 4.62 4.83 4.71 4.78 4.84 4.88
Noncontrolling Interest Sharing Ratio		 98.20% 90.60% 41.29% 36.78% 57.91% 35.36% 21.48% 18.73% 19.62% 20.02% 12.92%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.91 0.91 0.89 0.88 0.88 0.88 0.89 0.89 0.88 0.92 0.87
Quick Ratio		 0.50 0.45 0.47 0.47 0.48 0.48 0.50 0.52 0.50 0.51 0.48
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 2,509 408 774 -481 -103 1,691 -4.15 2,590 827 -1,757 -1,850
Operating Cash Flow to CapEx		 670.83% 937.68% 612.04% 714.35% 1,040.94% 1,192.66% -779.09% 2,101.81% 548.68% -2,567.48% 2,596.65%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 4.19 4.19 4.27 4.30 4.40 4.43 4.51 4.44 4.53 4.53 4.59
Accounts Receivable Turnover		 13.03 13.52 13.17 12.91 13.32 13.51 13.13 12.66 13.13 13.15 13.38
Inventory Turnover		 14.89 14.12 14.73 15.04 15.34 14.81 15.44 15.60 15.58 14.97 16.38
Fixed Asset Turnover		 111.02 113.27 115.44 119.66 122.79 127.59 130.46 134.24 136.20 143.79 141.26
Accounts Payable Turnover		 5.89 5.81 5.91 5.92 5.89 5.86 6.00 5.86 5.87 6.00 6.22
Days Sales Outstanding (DSO)		 28.01 27.00 27.72 28.28 27.40 27.02 27.81 28.84 27.80 27.76 27.27
Days Inventory Outstanding (DIO)		 24.51 25.86 24.78 24.27 23.79 24.65 23.64 23.40 23.42 24.38 22.28
Days Payable Outstanding (DPO)		 61.97 62.84 61.78 61.68 62.00 62.27 60.87 62.33 62.18 60.79 58.72
Cash Conversion Cycle (CCC)		 -9.46 -9.98 -9.28 -9.14 -10.81 -10.60 -9.42 -10.09 -10.96 -8.65 -9.16
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 2,386 4,026 3,905 4,553 2,862 2,968 4,408 2,485 2,042 5,286 7,058
Invested Capital Turnover		 68.89 60.82 61.01 62.83 99.92 77.67 66.54 80.65 119.89 73.47 54.12
Increase / (Decrease) in Invested Capital		 -2,154 100 -305 1,008 476 -1,058 503 -2,068 -820 2,319 2,650
Enterprise Value (EV)		 29,920 37,686 35,535 42,371 38,311 43,213 51,582 46,400 45,647 48,486 59,972
Market Capitalization		 27,323 33,482 31,912 38,504 35,972 41,157 48,258 44,840 44,251 43,426 53,926
Book Value per Share		 ($1.02) ($0.87) $1.39 $3.39 $2.58 $4.56 $5.43 $4.64 $3.28 $1.17 $5.22
Tangible Book Value per Share		 ($62.96) ($64.21) ($70.39) ($67.86) ($66.69) ($65.60) ($63.72) ($63.67) ($64.32) ($65.36) ($87.36)
Total Capital		 5,774 5,718 5,444 5,943 5,454 5,840 6,476 5,792 5,175 8,510 9,036
Total Debt		 5,703 5,644 4,933 5,021 4,787 4,779 5,249 4,731 4,388 8,149 7,856
Total Long-Term Debt		 4,632 4,656 4,667 4,160 4,146 4,186 4,180 4,166 3,812 5,935 7,086
Net Debt		 2,315 3,952 3,393 3,631 2,195 1,906 3,181 1,425 1,255 4,924 5,878
Capital Expenditures (CapEx)		 174 76 103 104 175 74 113 118 182 106 129
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -6,206 -4,756 -6,355 -6,325 -7,983 -8,194 -6,600 -8,408 -9,116 -5,534 -8,001
Debt-free Net Working Capital (DFNWC)		 -2,818 -3,064 -4,815 -4,936 -5,391 -5,322 -4,532 -5,101 -5,983 -2,309 -6,023
Net Working Capital (NWC)		 -3,888 -4,052 -5,081 -5,797 -6,032 -5,915 -5,601 -5,667 -6,559 -4,522 -6,793
Net Nonoperating Expense (NNE)		 56 32 40 48 24 30 78 34 0.09 68 83
Net Nonoperating Obligations (NNO)		 2,315 3,952 3,393 3,631 2,195 1,906 3,181 1,425 1,255 4,924 5,878
Total Depreciation and Amortization (D&A)		 174 175 245 277 284 278 280 281 280 281 264
Debt-free, Cash-free Net Working Capital to Revenue		 -2.60% -1.97% -2.57% -2.49% -3.05% -3.02% -2.39% -2.96% -3.10% -1.83% -2.58%
Debt-free Net Working Capital to Revenue		 -1.18% -1.27% -1.95% -1.94% -2.06% -1.96% -1.64% -1.80% -2.04% -0.76% -1.94%
Net Working Capital to Revenue		 -1.63% -1.68% -2.05% -2.28% -2.30% -2.18% -2.03% -2.00% -2.23% -1.49% -2.19%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.43 $2.35 $2.15 $2.37 $1.75 $3.01 $2.11 $2.44 $0.04 $2.52 $3.70
Adjusted Weighted Average Basic Shares Outstanding		 208.47M 204.03M 202.32M 202.35M 202.51M 200.08M 199.41M 198.26M 198.50M 193.76M 193.80M
Adjusted Diluted Earnings per Share		 $1.40 $2.33 $2.13 $2.35 $1.72 $2.98 $2.09 $2.42 $0.04 $2.50 $3.68
Adjusted Weighted Average Diluted Shares Outstanding		 211.21M 206.33M 204.26M 204.38M 204.59M 201.84M 201.18M 200.05M 200.28M 195.19M 195.09M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 205.67M 202.26M 202.47M 202.17M 200.71M 199.48M 199.45M 197.05M 193.28M 193.92M 193.82M
Normalized Net Operating Profit after Tax (NOPAT)		 431 548 613 540 456 615 791 586 215 643 927
Normalized NOPAT Margin		 0.70% 0.87% 0.97% 0.81% 0.66% 0.85% 1.16% 0.79% 0.27% 0.79% 1.23%
Pre Tax Income Margin		 0.63% 0.94% 0.81% 0.91% 0.65% 1.08% 0.68% 0.85% 0.16% 0.76% 1.23%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 23.50% 23.08% 25.23% 23.59% 23.02% 21.77% 22.13% 22.23% 27.39% 29.88% 24.94%
Augmented Payout Ratio		 52.53% 99.32% 106.93% 91.50% 91.16% 62.59% 65.85% 89.93% 125.56% 135.65% 112.30%

Key Financial Trends

Cencora reported strong second‐quarter 2025 results with notable revenue and earnings growth, robust operating cash flow, but continued heavy investing outflows and negative free cash flow.

  • Revenue grew 10.3% year-over-year to $75.45 billion in Q2 2025, marking the fourth consecutive quarter of double-digit growth.
  • EBITDA rose 59.9% year-over-year to $1.297 billion, driven by margin improvement and disciplined cost control.
  • Operating cash flow surged to $3.35 billion, compared with a $878 million outflow in Q2 2024, reflecting strong working-capital management.
  • Net income attributable to common shareholders increased 70.3% year-over-year to $717 million, lifting diluted EPS to $3.68.
  • Dividend yield remains modest at 0.76%, supported by a $0.55 / share quarterly payout (25% payout ratio).
  • Debt-to-EBITDA stands at 2.19×, in line with investment-grade peers and providing financial flexibility.
  • Valuation metrics: P/E of 31.8× and P/Rev of 0.17×, reflecting growth expectations in the pharmaceutical distribution sector.
  • Free cash flow to firm was negative $1.85 billion, weighed down by elevated capital spending and acquisitions.
  • Q2 investing activities included $3.95 billion on acquisitions, pressuring near-term cash flow and leverage.
  • Liquidity metrics remain stretched with a quick ratio of 0.48×, below the 1.0× benchmark for current-liability coverage.
06/19/25 01:50 PMAI Generated. May Contain Errors.

Frequently Asked Questions About Cencora's Financials

When does Cencora's fiscal year end?

According to the most recent income statement we have on file, Cencora's financial year ends in September. Their financial year 2024 ended on September 30, 2024.

How has Cencora's net income changed over the last 9 years?

Cencora's net income appears to be on an upward trend, with a most recent value of $1.52 billion in 2024, falling from -$138.17 million in 2015. The previous period was $1.73 billion in 2023. View Cencora's forecast to see where analysts expect Cencora to go next.

What is Cencora's operating income?
Cencora's total operating income in 2024 was $2.18 billion, based on the following breakdown:
  • Total Gross Profit: $9.91 billion
  • Total Operating Expenses: $7.73 billion
How has Cencora's revenue changed over the last 9 years?

Over the last 9 years, Cencora's total revenue changed from $135.96 billion in 2015 to $293.96 billion in 2024, a change of 116.2%.

How much debt does Cencora have?

Cencora's total liabilities were at $66.31 billion at the end of 2024, a 7.1% increase from 2023, and a 142.5% increase since 2015.

How much cash does Cencora have?

In the past 9 years, Cencora's cash and equivalents has ranged from $2.17 billion in 2015 to $4.60 billion in 2020, and is currently $3.13 billion as of their latest financial filing in 2024.

How has Cencora's book value per share changed over the last 9 years?

Over the last 9 years, Cencora's book value per share changed from 2.85 in 2015 to 3.28 in 2024, a change of 15.0%.


Related Companies

This page (NYSE:COR) was last updated on 6/19/2025 by MarketBeat.com Staff
From Our Partners
Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...
Priority Gold | Sponsored
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...
Paradigm Press | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
An AI run of epic proportions is only getting started
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Why July 22nd Could Mean Big Changes for Social Security
In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...
Altimetry | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...
Weiss Ratings | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored